Synairgen Share Discussion Threads

[141jaffa] 29/4/2020 20:10

Had to start in a hospital setting I suppose, but this drug seems much better suited to this setting. Progressing onto this phase and involving secondary care seems a very positive step to me. Interested to hear Nobby's view here ( I have no experience of clinical trials )

[crookie3634] 29/4/2020 20:07

Got to be an RNS tomorrow or Friday significant change to the trial. Is this the element we were fast tracked for?

Or were we struggling to get numbers and show the impact on patients?

How will the market read it? Seems sensible and adapting to challenges presented.

[royalalbert] 29/4/2020 20:03

And a snippet from that article, remember ours is controlled double blinded.

“This is uncontrolled, anecdotal data, which often winds up not being confirmed in controlled studies.”

[hazl] 29/4/2020 20:03

wolo means supercash I think ! lol

[peachie 74] 29/4/2020 19:52

What some positive news will do here also is potentially stop the presumed institutional seller. So no sells to hold back the rush of buys on some news. Win win hopefully

[peachie 74] 29/4/2020 19:49

Wally is Likya. !

FFS the lengths people go to to make some money !

[wolowitz] 29/4/2020 19:42

i am invested here amd

[pdt] 29/4/2020 19:39

Excellent news on trial expansion. Thanks for posting the link.

This gives two shots on goal. In theory IFN should work best when it is given at the earliest opportunity. It doesn't work on infected cells and if you have had COVID for a couple of weeks before you get to hospital you are going have a lot of infection.

If it can demonstrate benefit by treating people before they need to go to hospital it will mean hospitals can go back to normal since there will be less demand.

[wolowitz] 29/4/2020 19:38

supercrash .coming here.

[aquilla] 29/4/2020 19:36

Wd, they're not there yet. A week ago this was the news from an accidentally released report:
"The antiviral medicine remdesivir from Gilead Sciences failed to speed the improvement of patients with Covid-19 or prevent them from dying, according to results from a long-awaited clinical trial conducted in China."

[wetdream] 29/4/2020 19:32

Looks like a case of ‘America First’....

[vitec] 29/4/2020 19:03

By the way I had my suspicions this morning about wally and he has outed himself. He is Likya

[vitec] 29/4/2020 19:02

Partly true dave. I have a core holding in all of the companies and then a trading pot. That is what I swap over.

[grosstonnage] 29/4/2020 19:00

We need to have patients.

[hairballradical] 29/4/2020 18:48

Possibly a more thorough set of results over a greater range of the infection period but over a longer timeframe? It's independent of the hospital one so that should be progressing as it always would have done. I guess that the home based trial will have access to more trialists quicker.

[paradise city] 29/4/2020 18:44

Yes not sure it's going to help the share price , any delay will knock confidence imo !!

[hairballradical] 29/4/2020 18:36

Paradise,

ok so that's an amendment made today to extend the testing to home trials at an earlier stage. It does broaden the trial but would give a double result, one at an early phase of the disease and SNG001 impact and much later in the disease and it's impact.

On balance overall it's better for potential results but it may impact the timeframe for the results?

[paradise city] 29/4/2020 18:25

Courtesy of a poster in LSE !https://www.hra.nhs.uk/covid-19-research/approved-covid-19-research/281317/

[hairballradical] 29/4/2020 18:17

Nobby,

is Remdesivir a competitor as such to SNG?

Thanks in advance

[dave444] 29/4/2020 17:10

No he just switches in and out!

[arab3] 29/4/2020 17:07

I think vitec always has plenty of spare cash the way he constantly buys shares !

[cambradjones] 29/4/2020 17:00

Well you have plenty of spare cash after today.